A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
When I tell people I direct clinical research studies, I often encounter surprise. “Aren’t you a physician?” they ask. It ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
The prevalence of diabetes is increasing faster in some low-income countries than elsewhere in the world, generating concerns ...
SLW: The part of dairy that is very well-positioned to assist consumers on their GLP-1 journey is yogurt. The functional ...
A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results